Bristol Myers Squibb (NYSE:BMY) has agreed to acquire privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash. Orbital Therapeutics is advancing a new generation of RNA ...

We may earn a commission from links on this page. Deal pricing and availability subject to change after time of publication. Amazon Big Deal Days end tonight, Oct. 8, and until then, Lifehacker is ...

Aerospace and defense company Inversion is showing off its solution to getting emergency supplies anywhere on Earth in under an hour. It's a constellation of the company's Arc orbital supply craft, ...

BMS will acquire Orbital Therapeutics and its CAR T-cell therapy OTX-201 to diversify its cell therapy portfolio. The acquisition involves a $1.5 billion cash transaction, subject to customary closing ...

A temporary reduction in upper atmospheric density would slow the orbital decay. It would directly lowers aerodynamic drag on the satellite. This density variation is a natural consequence of space ...

Scientists have begun to unravel the origin story of a cataclysmic collision between two black holes, which seem to have met their fate on a rarely observed "squashed" orbital path. The binary black ...

INDIANAPOLIS -- Indianapolis Colts backup quarterback Anthony Richardson suffered an orbital fracture to his eye prior to Sunday's 31-27 victory over the Arizona Cardinals, according to coach Shane ...

It's just 18 light-years away: a super-Earth named GJ 251c with a minimum mass about 3.84 times that of our own planet. The ...

PRINCETON/CAMBRIDGE - Bristol Myers Squibb (NYSE:BMY), currently trading at $3.20 and showing potential upside according to InvestingPro Fair Value metrics, announced Thursday it has entered into a ...